MIP and malaria: Although other candidate therapies, such as dihydroartemisinin-piperaquine, are still being investigated, and despite waning SP efficacy due to increasing parasite resistance, SP remains an essential component of MiP prevention in malaria-endemic areas [10,35,45,50,56].